Week one FLT-PET response predicts complete remission to R-CHOP and survival in DLBCL

Despite improved survival in the Rituximab (R) era, a considerable number of patients with diffuse large B-cell lymphoma (DLBCL) ultimately die from the disease. Functional imaging using [(18)F]fluorodeoxyglucose-PET is suggested for assessment of residual viable tumor very early during treatment bu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Herrmann, Ken, Buck, Andreas K., Schuster, Tibor, Abbrederis, Kathrin, Blümel, Christina, Santi, Ivan, Rudelius, Martina, Wester, Hans-Jürgen, Peschel, Christian, Schwaiger, Markus, Dechow, Tobias, Keller, Ulrich
Format: Artigo
Sprache:Inglês
Veröffentlicht: Impact Journals LLC 2014
Schlagworte:
Clinical Research Paper
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4147305/
https://ncbi.nlm.nih.gov/pubmed/24979177
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge